REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Frey Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: All Other Food Manufacturing | Pharmaceutical Preparation Manufacturing | Department Stores | Electronic Shopping and Mail-Order Houses | Other Direct Selling Establishments | Warehousing and Storage | Internet Publishing and Broadcasting and Web Search Portals
Full name: Frey Pharma Sp. z o.o. Profile Updated: December 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Frey Pharma Sp. z o.o. is a company in Poland, with a head office in Ostrow Wielkopolski. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was incorporated on May 18, 2020. The latest financial highlights indicate a net sales revenue increase of 258.94% in 2022. Its total assets grew by 82.4% over the same period. The net profit margin of Frey Pharma Sp. z o.o. increased by 28.2% in 2022.

Headquarters
Ul. Jana Danysza 4
Ostrow Wielkopolski; Wielkopolskie; Postal Code: 63-400

Contact Details: Purchase the Frey Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Frey Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Frey Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 18, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Frey Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
258.94%▲
Total operating revenue
258.88%▲
Operating profit (EBIT)
1153.82%▲
Net Profit (Loss) for the Period
1029.94%▲
Total assets
82.4%▲
Total equity
N/A
Operating Profit Margin (ROS)
32.72%▲
Net Profit Margin
28.2%▲
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
0.47%▲
Cash Ratio
0.49%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo